Patients with retinal artery occlusion experience reduced contrast sensitivity, suggesting the potential for a new functional test.
Canadian medical device company MacuMira Medical Devices recently introduced the first Health Canada-approved treatment to ...
CNW/ - MacuMira Medical Devices Inc. introduces the first Health Canada-approved treatment to improve visual function for ...
Cost is another issue, because people often ration eye tests as they are worried about paying for glasses. This prevents ...
Increasing vision loss contributes to greater balance and mobility challenges in patients with maculopathy, a study shows.
Visual symptoms in Parkinson’s disease may remain largely unchanged despite treatment with levodopa or deep brain stimulation ...
From gentle oil cleansers to top sheet masks, we asked professionals for their thoughts on how to build a 10-step Korean ...
Current clinical protocols predominantly utilize mononuclear gadolinium(III) complexes as contrast agents. Recently, ...
A single phototransistor mimics retinal bipolar cell function while detecting visible and infrared light, enabling low-power ...
Live Science on MSN
Scientific breakthrough leads to 'fluorescent biological qubit' — it could mean turning your cells into quantum sensors
Fluorescent proteins can be turned into qubits within cells and could give us a deeper understanding of biology at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results